Synthesis, antitubercular and anticancer activity of new Baylis-Hillman adduct-derived N-cinnamyl-substituted isatin derivatives

39Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Baylis-Hillman adduct-derived N-cinnamyl-substituted isatin derivatives were synthesized and evaluated for their antitubercular activity on Mycobacterium tuberculosis H37Rv strain ATCC 27294 by agar dilution method. Anticancer activity for the same compounds was also screened on four different cell lines: Chinese hamster ovary (CHO cells), Colo 205 (human colon cancer), Sup- T1 (human lymphoma) and C6 glioma (rat glioma) by MTT assay method. The compounds (3j-l) have shown significant activity against Mycobacterium strain and the compound 3l has shown specific cytotoxic activity. © Springer Science+Business Media 2013.

Cite

CITATION STYLE

APA

Kumar, S. B., Ravinder, M., Kishore, G., Jayathirtha Rao, V., Yogeeswari, P., & Sriram, D. (2014). Synthesis, antitubercular and anticancer activity of new Baylis-Hillman adduct-derived N-cinnamyl-substituted isatin derivatives. Medicinal Chemistry Research, 23(4), 1934–1940. https://doi.org/10.1007/s00044-013-0787-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free